Loading…

6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity

Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methyl...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1996-04, Vol.39 (8), p.1720-1728
Main Authors: Felczak, Krzysztof, Drabikowska, Alicja K, Vilpo, Juhani A, Kulikowski, Tadeusz, Shugar, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903
cites cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903
container_end_page 1728
container_issue 8
container_start_page 1720
container_title Journal of medicinal chemistry
container_volume 39
creator Felczak, Krzysztof
Drabikowska, Alicja K
Vilpo, Juhani A
Kulikowski, Tadeusz
Shugar, David
description Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.
doi_str_mv 10.1021/jm950675q
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78030906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78030906</sourcerecordid><originalsourceid>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</originalsourceid><addsrcrecordid>eNptkc9uEzEQhy0EKmnhwAMg-QBISFnwv_Xucgst0EqVqEjKgYvl9c4qDrt2antbcuPKY_BqPAkbEiIOnCzN9_k3oxmEnlDyihJGX6_6KieyyG_uoQnNGclEScR9NCGEsYxJxh-i4xhXhBBOGT9CR6UUpaR0gn7KbD7UMdk0JGiwdg3OpzI7s_Gf6hkEe6uTvYWIfYuvg22sgze_vv_A8wQBfIQOzJbj-calJUQbp_jCjUyPZe_wnU3Lv__w1dLH9dKHTacjTP_0tA5_til4PHPbpr0PeLYNtGnzCD1odRfh8f49Qdfv3y1Oz7PLjx8uTmeXmeZFkbKWVIaRpqx1WReQUyoFoy01dVuZsq1q0Jxq1gJreGlkzYUQtdRQGSEkbSvCT9CLXe46-JsBYlK9jQa6TjvwQ1RFSTipiBzFlzvRBB9jgFatg-112ChK1PYc6nCO0X26Dx3qHpqDud__yJ_tuY5Gd23Qzth40DgRJa3YqGU7zcYE3w5Yh69KFrzI1eJqrt4uzhefxBeitiM-3_naRLXyQ3Dj5v4z3m-1xrGH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78030906</pqid></control><display><type>article</type><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</creator><creatorcontrib>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</creatorcontrib><description>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm950675q</identifier><identifier>PMID: 8648611</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; General aspects ; Humans ; Medical sciences ; Molecular Conformation ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Tumor Cells, Cultured ; Uridine - chemical synthesis ; Uridine - chemistry ; Uridine - pharmacology ; Uridine Phosphorylase - metabolism</subject><ispartof>Journal of medicinal chemistry, 1996-04, Vol.39 (8), p.1720-1728</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</citedby><cites>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3048192$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8648611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Felczak, Krzysztof</creatorcontrib><creatorcontrib>Drabikowska, Alicja K</creatorcontrib><creatorcontrib>Vilpo, Juhani A</creatorcontrib><creatorcontrib>Kulikowski, Tadeusz</creatorcontrib><creatorcontrib>Shugar, David</creatorcontrib><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured</subject><subject>Uridine - chemical synthesis</subject><subject>Uridine - chemistry</subject><subject>Uridine - pharmacology</subject><subject>Uridine Phosphorylase - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNptkc9uEzEQhy0EKmnhwAMg-QBISFnwv_Xucgst0EqVqEjKgYvl9c4qDrt2antbcuPKY_BqPAkbEiIOnCzN9_k3oxmEnlDyihJGX6_6KieyyG_uoQnNGclEScR9NCGEsYxJxh-i4xhXhBBOGT9CR6UUpaR0gn7KbD7UMdk0JGiwdg3OpzI7s_Gf6hkEe6uTvYWIfYuvg22sgze_vv_A8wQBfIQOzJbj-calJUQbp_jCjUyPZe_wnU3Lv__w1dLH9dKHTacjTP_0tA5_til4PHPbpr0PeLYNtGnzCD1odRfh8f49Qdfv3y1Oz7PLjx8uTmeXmeZFkbKWVIaRpqx1WReQUyoFoy01dVuZsq1q0Jxq1gJreGlkzYUQtdRQGSEkbSvCT9CLXe46-JsBYlK9jQa6TjvwQ1RFSTipiBzFlzvRBB9jgFatg-112ChK1PYc6nCO0X26Dx3qHpqDud__yJ_tuY5Gd23Qzth40DgRJa3YqGU7zcYE3w5Yh69KFrzI1eJqrt4uzhefxBeitiM-3_naRLXyQ3Dj5v4z3m-1xrGH</recordid><startdate>19960412</startdate><enddate>19960412</enddate><creator>Felczak, Krzysztof</creator><creator>Drabikowska, Alicja K</creator><creator>Vilpo, Juhani A</creator><creator>Kulikowski, Tadeusz</creator><creator>Shugar, David</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960412</creationdate><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><author>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured</topic><topic>Uridine - chemical synthesis</topic><topic>Uridine - chemistry</topic><topic>Uridine - pharmacology</topic><topic>Uridine Phosphorylase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Felczak, Krzysztof</creatorcontrib><creatorcontrib>Drabikowska, Alicja K</creatorcontrib><creatorcontrib>Vilpo, Juhani A</creatorcontrib><creatorcontrib>Kulikowski, Tadeusz</creatorcontrib><creatorcontrib>Shugar, David</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Felczak, Krzysztof</au><au>Drabikowska, Alicja K</au><au>Vilpo, Juhani A</au><au>Kulikowski, Tadeusz</au><au>Shugar, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-04-12</date><risdate>1996</risdate><volume>39</volume><issue>8</issue><spage>1720</spage><epage>1728</epage><pages>1720-1728</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8648611</pmid><doi>10.1021/jm950675q</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1996-04, Vol.39 (8), p.1720-1728
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_78030906
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - pharmacology
Biological and medical sciences
General aspects
Humans
Medical sciences
Molecular Conformation
Pharmacology. Drug treatments
Structure-Activity Relationship
Tumor Cells, Cultured
Uridine - chemical synthesis
Uridine - chemistry
Uridine - pharmacology
Uridine Phosphorylase - metabolism
title 6-Substituted and 5,6-Disubstituted Derivatives of Uridine:  Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A14%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=6-Substituted%20and%205,6-Disubstituted%20Derivatives%20of%20Uridine:%E2%80%89%20Stereoselective%20Synthesis,%20Interaction%20with%20Uridine%20Phosphorylase,%20and%20in%20Vitro%20Antitumor%20Activity&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Felczak,%20Krzysztof&rft.date=1996-04-12&rft.volume=39&rft.issue=8&rft.spage=1720&rft.epage=1728&rft.pages=1720-1728&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm950675q&rft_dat=%3Cproquest_cross%3E78030906%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78030906&rft_id=info:pmid/8648611&rfr_iscdi=true